Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27721981

CC(C)(C)OC=O.NCCC1CCNCC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
ANPEP P15144 1/20 0.33
ERAP2 Q6P179 1/20 0.33
ITGB3 P05106 2/20 0.32
ITGA2B P08514 2/20 0.32
KDM1A O60341 1/20 0.31
HTR4 Q13639 1/20 0.30
SLC6A1 P30531 2/20 0.30
GABRA5 P31644 2/20 0.30
GABRB2 P47870 2/20 0.30
SLC6A12 P48065 2/20 0.30
SLC6A11 P48066 2/20 0.30
SLC6A13 Q9NSD5 2/20 0.30
GABRA1 P14867 1/20 0.30
GABRR1 P24046 1/20 0.30
GABRA4 P48169 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27742718 0.90 TDP1 (0.41) TDP1ANPEPERAP2ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL27779744 0.90 TDP1 (0.41) TDP1ANPEPERAP2ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL27722913 0.90 TDP1 (0.50) TDP1ANPEPERAP2ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL27663311 0.88 TDP1 (0.45) TDP1ANPEPERAP2ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL28050472 0.88 TDP1 (0.45) TDP1ANPEPERAP2ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL27702406 0.88 TDP1 (0.48) TDP1ANPEPERAP2ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL27923537 0.88 TDP1 (0.52) TDP1
Tert-Butyl Formate SCHEMBL27765046 0.87 TDP1 (0.43) TDP1ANPEPERAP2KDM1ASLC6A1
Tert-Butyl Formate SCHEMBL27698140 0.85 TDP1 (0.45) TDP1
Tert-Butyl Formate SCHEMBL27562936 0.83 TDP1 (0.43) TDP1ANPEPERAP2ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110437153-A hepatitis B core protein allosteric modulators UNIV INDIANA RES & TECH CORP 2019-11-12 CN disclosed
CN-108884070-A PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS 葛兰素史克知识产权第二有限公司 2018-11-23 CN disclosed
CN-108884083-A Benzo [ B ] furans as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2018-11-23 CN disclosed
CN-106413402-A Hepatitis b core protein allosteric modulators 美国印第安纳大学研究和技术公司 2017-02-15 CN disclosed
CN-105473575-A Benzimidazolyl-methylurea derivatives as ALX receptor agonists ACTELION PHARMACEUTICALS LTD 2016-04-06 CN disclosed
CN-105339371-A Thieno[3,2-d]pyrimidine-6-carboxamides and analogues as sirtuin modulators GLAXOSMITHKLINE LLC 2016-02-17 CN disclosed
CN-104968656-A AUTOTAXIN INHIBITORS NOVARTIS AG 2015-10-07 CN disclosed
CN-103068797-B Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application SANOFI SA 2015-03-11 CN disclosed
CN-102232076-B Pyrrolopyrazinyl urea kinase inhibitors HOFFMANN LA ROCHE 2014-12-31 CN disclosed
CN-102164920-B Alkylthiazole carbamate derivatives, method for the production thereof and use thereof as FAAH enzyme inhibitors SANOFI AVENTIS 2013-12-25 CN disclosed
CN-102232076-A Pyrrolopyrazinyl urea kinase inhibitors HOFFMANN LA ROCHE 2011-11-02 CN disclosed
CN-102164920-A Alkylthiazole carbamate derivatives, method for the production thereof and use thereof as FAAH enzyme inhibitors SANOFI AVENTIS 2011-08-24 CN disclosed
CN-101309918-B [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI 2010-12-29 CN disclosed
CN-101528680-A New phenylsulfamoyl benzamide derivatives as bradykinin antagonists RICHTER GEDEON NYRT (HU) 2009-09-09 CN disclosed
CN-101309918-A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI (US) 2008-11-19 CN disclosed
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN disclosed